Work

Trial in progress: Feasibility of CSF and plasma ctDNA in BRAF-altered glioma during treatment with plixorafenib.

Year: 2025

Type: article

Study design: Study Protocol

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps2098

Authors: Karisa C. Schreck, Grace Tobin, Peng Huang, Michaella Iacoboni, Joy D. Fisher, Chetan Bettegowda

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, National Institutes of Health

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410818185

FWCI:

Cites:

Cited by:

Related to: 10